Abstract
Heart transplantation has become the most effective therapy for end-stage congestive heart failure. Since the first human-to-human transplant in 1967, outcomes have changed from relatively poor to a mean survival of more than 11 years, according to data reported in 2012. These improved outcomes and increased numbers of patients receiving orthotopic heart transplants are due to multiple reasons, including changes in immunosuppressive drugs, better management of heart failure patients on the waiting list, increasing use of ventricular assist devices (VADs) as bridge support, improved VAD technology, and improved donor organ preservation. Much of this chapter focuses on details of the orthotopic transplantation procedure itself. Other sections describe the steps involved in accepting transplant recipients and potential contraindications and how patients are prepared for the transplant. Criteria for donor acceptance are also described, as is the critical nature of the target time frame from donor heart availability to transplant, how a donor heart is checked for viability, considerations of posttransplant care including management of immunosuppressive agents, and monitoring for various types of potential rejection and how to treat them.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the +canine heart. Surg Forum. 1960;11:18–9.
Barnard CN. What we have learned about heart transplants. J Thorac Cardiovasc Surg. 1968;56(4):457–68.
Bolman 3rd RM, Elick B, Olivari MT, Ring WS, Arentzen CE. Improved immunosuppression for heart transplantation. J Heart Transplant. 1985;4(3):315–8.
Baran DA, Galin ID, Gass AL. Current practices: immunosuppression induction, maintenance, and rejection regimens in contemporary post-heart transplant patient treatment. Curr Opin Cardiol. 2002;17(2):165–70.
Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI, International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012. J Heart Lung Transplant. 2012;31(10):1052–64.
Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodeheffer RJ, Kenzora JL. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13(3):353–64.
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, PROCEED II trial investigators. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;27:2577–84.
Bolman 3rd RM. Cardiac transplantation: the operative technique. Cardiovasc Clin. 1990;20(2):133–45.
Liao KK, Bolman 3rd RM. Operative techniques in orthotopic heart transplantation. Semin Thorac Cardiovasc Surg. 2004;16(4):370–7.
John R, Liao K. Orthotopic heart transplantation. Oper Tech Thorac Cardiovasc Surg. 2010;15(2):138–46.
Sievers HH, Weyand M, Kraatz EG, Bernhard A. An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium. Thorac Cardiovasc Surg. 1991;39(2):70–2.
Sarsam MA, Campbell CS, Yonan NA, Deiraniya AK, Rahman AN. An alternative surgical technique in orthotopic cardiac transplantation. J Card Surg. 1993;8(3):344–9.
Grande AM, Rinaldi M, D’Armini CC, Traversi E, Pederzolli C, Abbiate N, Klersy C, Viganò M. Orthotopic heart transplantation: standard versus bicaval technique. Am J Cardiol. 2000;85(11):1329–33.
Leyh RG, Jahnke AW, Kraatz EG, Sievers HH. Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation. Ann Thorac Surg. 1995;59(6):1495–500.
el-Gamel A, Deiraniya AK, Rahman AN, Campbell CS, Yonan NA. Orthotopic heart transplantation hemodynamics: does atrial preservation improve cardiac output after transplantation? J Heart Lung Transplant. 1996;15(6):564–71.
Beniaminovitz A, Savoia MT, Oz M, Galantowicz M, Di Tullio MR, Homma S, Mancini D. Improved atrial function in bicaval versus standard orthotopic techniques in cardiac transplantation. Am J Cardiol. 1997;80(12):1631–5.
Liao K, Shumway S. Cardiac transplantation. In: Yuh D, Vricella LA, Yang S, Doty JR, editors. Johns Hopkins textbook of cardiothoracic surgery. 2nd ed. New York: McGraw-Hill Medical; 2014. p. 783–95.
Stinson EB, Caves PK, Griepp RB, Oyer PE, Rider AK, Shumway NE. Hemodynamic observations in the early period after human heart transplantation. J Thorac Cardiovasc Surg. 1975;69(2):264–70.
Cooper MM, Smith CR, Rose EA, Schneller SJ, Spotnitz HM. Permanent pacing following cardiac transplantation. J Thorac Cardiovasc Surg. 1992;104(3):812–6.
Liao K, Shumway S, Colvin-Adams M, Missov E, Ranjit J. Abstract 296: intermediate clinical performance of the levitronix centrimag ventricular assist device in supporting cardiogenic shock patients. Circulation. 2010;122:A296.
Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638–41.
Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet. 1999;353(9158):1083–91.
Halloran PF, Gourishankar S. Principles and overview of immunosuppression. In: Norman DJ, Turka LA, editors. Primer on transplantation. Mt Laurel, NJ: American Society of Transplantation; 2001. p. 87–98.
Kobashigawa J, Miller L, Russell S, et al. Randomized, prospective, multi-center comparison of tacrolimus, mycophenolate mofetil (MMF) and steroids vs tacrolimus, sirolimus and steroids vs cyclosporine, MMF and steroids in de novo cardiac transplant recipients 6-month report. J Heart Lung Transplant. 2004;23(suppl):S106.
Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med. 2000;342(9):613–9.
Tan CD, Baldwin 3rd WM, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med. 2007;131(8):1169–91.
Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9(6):587–93.
Michaels PJ, Espejo ML, Kobashigawa J, Alejos JC, Burch C, Takemoto S, Reed EF, Fishbein MC. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22(1):58–69.
Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay Jr WA, Jones KW, O’Connell JB. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant. 1989;8(6):430–43.
Park MH, Starling RC, Ratliff NB, McCarthy PM, Smedira NS, Pelegrin D, Young JB. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection. J Heart Lung Transplant. 1999;18(12):1224–7.
Krasinskas AM, Kreisel D, Acker MA, Bavaria JE, Pochettino A, Kotloff RM, Arcasoy S, Blumenthal N, Kamoun M, Moore JS, Rosengard BR. CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation. Transplantation. 2002;73(8):1339–41.
Adamson R, Obispo E, Dychter S, Dembitsky W, Moreno-Cabral R, Jaski B, Gordon J, Hoagland P, Moore K, King J, Andrews J, Rich M, Daily PO. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Transplant Proc. 1998;30(4):1107–9.
Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Kucheryavaya AY, Rahmel AO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth official adult heart transplant report–2009. J Heart Lung Transplant. 2009;28(10):1007–22.
Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report–2010. J Heart Lung Transplant. 2010;29(10):1089–103.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Liao, K.K., John, R., Shumway, S.J. (2017). Orthotopic Heart Transplantation. In: Garry, D., Wilson, R., Vlodaver, Z. (eds) Congestive Heart Failure and Cardiac Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-44577-9_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-44577-9_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44575-5
Online ISBN: 978-3-319-44577-9
eBook Packages: MedicineMedicine (R0)